Molecular interaction of artemisinin with translationally controlled tumor protein (TCTP) of Plasmodium falciparum.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 23085438)

Published in Biochem Pharmacol on October 17, 2012

Authors

Tolga Eichhorn1, Dominic Winter, Berthold Büchele, Natalie Dirdjaja, Martin Frank, Wolf-Dieter Lehmann, Rolf Mertens, R Luise Krauth-Siegel, Thomas Simmet, Joachim Granzin, Thomas Efferth

Author Affiliations

1: Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany.

Articles citing this

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature (2013) 11.03

Haem-activated promiscuous targeting of artemisinin in Plasmodium falciparum. Nat Commun (2015) 1.90

Structural divergence of plant TCTPs. Front Plant Sci (2014) 0.87

The Plasmodium falciparum translationally controlled tumor protein (TCTP) is incorporated more efficiently into B cells than its human homologue. PLoS One (2014) 0.83

Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites. J Nat Med (2016) 0.81

Treatment of Iron-Loaded Veterinary Sarcoma by Artemisia annua. Nat Prod Bioprospect (2014) 0.77

Updates on artemisinin: an insight to mode of actions and strategies for enhanced global production. Protoplasma (2015) 0.77

An integrative analysis of small molecule transcriptional responses in the human malaria parasite Plasmodium falciparum. BMC Genomics (2015) 0.77

Evolutionarily conserved binding of translationally controlled tumor protein to eukaryotic elongation factor 1B. J Biol Chem (2015) 0.76

Organism-like formation of Schistosoma hemozoin and its function suggest a mechanism for anti-malarial action of artemisinin. Sci Rep (2016) 0.75

In vitro selection of Plasmodium falciparum Pfcrt and Pfmdr1 variants by artemisinin. Malar J (2016) 0.75

Muddled mechanisms: recent progress towards antimalarial target identification. F1000Res (2016) 0.75

Characterization of recombinant Trypanosoma brucei gambiense Translationally Controlled Tumor Protein (rTbgTCTP) and its interaction with Glossina midgut bacteria. Gut Microbes (2017) 0.75

Articles by these authors

PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell (2011) 5.98

Molecular basis of transmembrane signalling by sensory rhodopsin II-transducer complex. Nature (2002) 2.65

GLYCOSCIENCES.de: an Internet portal to support glycomics and glycobiology research. Glycobiology (2005) 2.41

Thiol-based redox metabolism of protozoan parasites. Trends Parasitol (2003) 2.25

The Cenozoic palaeoenvironment of the Arctic Ocean. Nature (2006) 2.21

Data mining the protein data bank: automatic detection and assignment of carbohydrate structures. Carbohydr Res (2004) 1.89

Carbohydrate Structure Suite (CSS): analysis of carbohydrate 3D structures derived from the PDB. Nucleic Acids Res (2005) 1.84

Cameroonian medicinal plants: pharmacology and derived natural products. Front Pharmacol (2010) 1.80

Chemotherapy-induced resistance by ATP-binding cassette transporter genes. Biochim Biophys Acta (2007) 1.79

Molecular principles of cancer invasion and metastasis (review). Int J Oncol (2009) 1.66

Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano (2011) 1.66

Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma. Acta Neuropathol (2012) 1.56

Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo. Cancer Res (2008) 1.53

Impact Factors--The Bane of Our Existence. Physiologist (2015) 1.51

Evidence-based Chinese medicine for cancer therapy. J Ethnopharmacol (2007) 1.47

GlycomeDB--a unified database for carbohydrate structures. Nucleic Acids Res (2010) 1.46

Cytotoxicity of some Cameroonian spices and selected medicinal plant extracts. J Ethnopharmacol (2011) 1.46

Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma. Cancer Res (2009) 1.42

Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem (2010) 1.41

Antimicrobial activity of clove and rosemary essential oils alone and in combination. Phytother Res (2007) 1.39

Plasmin as a proinflammatory cell activator. J Leukoc Biol (2012) 1.38

The serine protease plasmin triggers expression of MCP-1 and CD40 in human primary monocytes via activation of p38 MAPK and janus kinase (JAK)/STAT signaling pathways. J Biol Chem (2002) 1.36

Intracellular interleukin-1alpha functionally interacts with histone acetyltransferase complexes. J Biol Chem (2003) 1.32

Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes. Cancer Res (2004) 1.32

Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigen-presenting cells. Blood (2003) 1.32

Glycome-DB.org: a portal for querying across the digital world of carbohydrate sequences. Glycobiology (2009) 1.31

Theoretical and experimental analysis links isoform-specific ERK signalling to cell fate decisions. Mol Syst Biol (2009) 1.31

Artesunate derived from traditional Chinese medicine induces DNA damage and repair. Cancer Res (2008) 1.31

Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: a clue to pathogenesis. Inflamm Bowel Dis (2009) 1.30

Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol (2004) 1.28

Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res (2013) 1.27

Modulation of human BCRP (ABCG2) activity by anti-HIV drugs. J Antimicrob Chemother (2007) 1.27

Bioinformatics for glycomics: status, methods, requirements and perspectives. Brief Bioinform (2004) 1.27

A conceptually new treatment approach for relapsed glioblastoma: coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget (2013) 1.27

Plasmin triggers cytokine induction in human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol (2007) 1.27

When less can yield more - Computational preprocessing of MS/MS spectra for peptide identification. Proteomics (2009) 1.24

Artesunate as a potent antiviral agent in a patient with late drug-resistant cytomegalovirus infection after hematopoietic stem cell transplantation. Clin Infect Dis (2008) 1.23

Ubiquitin protein ligase Nedd4 binds to connexin43 by a phosphorylation-modulated process. J Cell Sci (2006) 1.21

Use of CpG island microarrays to identify colorectal tumors with a high degree of concurrent methylation. Methods (2002) 1.21

The thioredoxin system as a therapeutic target in human health and disease. Antioxid Redox Signal (2013) 1.20

Antibacterial activity and anticancer activity of Rosmarinus officinalis L. essential oil compared to that of its main components. Molecules (2012) 1.20

Conformational dynamics of helix 8 in the GPCR rhodopsin controls arrestin activation in the desensitization process. Proc Natl Acad Sci U S A (2011) 1.19

Artesunate in the treatment of metastatic uveal melanoma--first experiences. Oncol Rep (2005) 1.19

Substrate specificity, localization, and essential role of the glutathione peroxidase-type tryparedoxin peroxidases in Trypanosoma brucei. J Biol Chem (2005) 1.18

Glyoxalase II of African trypanosomes is trypanothione-dependent. J Biol Chem (2004) 1.17

Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice. Arterioscler Thromb Vasc Biol (2007) 1.17

Acetyl-boswellic acids inhibit lipopolysaccharide-mediated TNF-alpha induction in monocytes by direct interaction with IkappaB kinases. J Immunol (2005) 1.17

Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials (2010) 1.16

The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res (2005) 1.14

Leishmaniasis: drug resistance and natural products (review). Int J Mol Med (2008) 1.13

EUROCarbDB: An open-access platform for glycoinformatics. Glycobiology (2010) 1.13

Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood (2009) 1.13

Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses. Nat Nanotechnol (2013) 1.12

Lysosomal degradation of the carboxydextran shell of coated superparamagnetic iron oxide nanoparticles and the fate of professional phagocytes. Biomaterials (2010) 1.12

Anticancer activities of six selected natural compounds of some Cameroonian medicinal plants. PLoS One (2011) 1.12

Amino-functionalized polystyrene nanoparticles activate the NLRP3 inflammasome in human macrophages. ACS Nano (2011) 1.12

Identification of the annexin A2 heterotetramer as a receptor for the plasmin-induced signaling in human peripheral monocytes. Blood (2005) 1.11

ABCA3 as a possible cause of drug resistance in childhood acute myeloid leukemia. Clin Cancer Res (2006) 1.11

Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an "in vitro" replicative system. Antiviral Res (2005) 1.10

Artesunate induces oxidative DNA damage, sustained DNA double-strand breaks, and the ATM/ATR damage response in cancer cells. Mol Cancer Ther (2011) 1.10

An NF-kappaB and slug regulatory loop active in early vertebrate mesoderm. PLoS One (2006) 1.09

Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med (2006) 1.09

Polo-like kinase 1 as target for cancer therapy. Exp Hematol Oncol (2012) 1.09

Molecular biology of cantharidin in cancer cells. Chin Med (2007) 1.08

Mode of cell death induction by pharmacological vacuolar H+-ATPase (V-ATPase) inhibition. J Biol Chem (2012) 1.08

The effect of carboxydextran-coated superparamagnetic iron oxide nanoparticles on c-Jun N-terminal kinase-mediated apoptosis in human macrophages. Biomaterials (2010) 1.08

First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int J Cancer (2010) 1.07

Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. J Ethnopharmacol (2010) 1.06

Role of transferrin receptor and the ABC transporters ABCB6 and ABCB7 for resistance and differentiation of tumor cells towards artesunate. PLoS One (2007) 1.06

Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG. Cancer (2012) 1.05

Human B cells differentiate into granzyme B-secreting cytotoxic B lymphocytes upon incomplete T-cell help. Immunol Cell Biol (2011) 1.05

Cytotoxicity and modes of action of four Cameroonian dietary spices ethno-medically used to treat cancers: Echinops giganteus, Xylopia aethiopica, Imperata cylindrica and Piper capense. J Ethnopharmacol (2013) 1.04

MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60. Cancer Genomics Proteomics (2010) 1.04

Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res (2011) 1.04

High throughput screening against the peroxidase cascade of African trypanosomes identifies antiparasitic compounds that inactivate tryparedoxin. J Biol Chem (2012) 1.04

Inhibition of IkappaB kinase activity by acetyl-boswellic acids promotes apoptosis in androgen-independent PC-3 prostate cancer cells in vitro and in vivo. J Biol Chem (2004) 1.03

Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol (2009) 1.03

4-Chloro-alpha-cyanocinnamic acid is an advanced, rationally designed MALDI matrix. Proc Natl Acad Sci U S A (2008) 1.03

A structure-guided mutation in the major capsid protein retargets BK polyomavirus. PLoS Pathog (2013) 1.02

Shikonin directly targets mitochondria and causes mitochondrial dysfunction in cancer cells. Evid Based Complement Alternat Med (2012) 1.02

CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. Eur J Immunol (2010) 1.02

Cajanol, a novel anticancer agent from Pigeonpea [Cajanus cajan (L.) Millsp.] roots, induces apoptosis in human breast cancer cells through a ROS-mediated mitochondrial pathway. Chem Biol Interact (2010) 1.02

Unique conformer selection of human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins. Biochemistry (2003) 1.02

A second class of peroxidases linked to the trypanothione metabolism. J Biol Chem (2002) 1.02

An alternative mechanism for amidase signature enzymes. J Mol Biol (2002) 1.02

Effect of artemisinins and other endoperoxides on nitric oxide-related signaling pathway in RAW 264.7 mouse macrophage cells. Nitric Oxide (2008) 1.02

Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells. Proc Natl Acad Sci U S A (2009) 1.02

Human cytomegalovirus infection and atherothrombosis. J Thromb Thrombolysis (2012) 1.01

Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ Res (2011) 1.01

Depletion of the thioredoxin homologue tryparedoxin impairs antioxidative defence in African trypanosomes. Biochem J (2007) 1.01

The role of informatics in glycobiology research with special emphasis on automatic interpretation of MS spectra. Biochim Biophys Acta (2005) 1.01

Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets. J Med Chem (2006) 1.00

Therapeutic and diagnostic applications of nanoparticles. Curr Drug Targets (2011) 1.00

Drug resistance in Plasmodium: natural products in the fight against malaria. Mini Rev Med Chem (2009) 1.00

Rare is frequent and frequent is costly: rare diseases as a challenge for health care systems. Eur J Health Econ (2015) 1.00

Biological activities of xanthatin from Xanthium strumarium leaves. Phytother Res (2011) 0.99